Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment

NCT00162097 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections
Hepatic Impairment

Interventions

DRUG: efavirenz containing antiretroviral regimen
DRUG: efavirenz containing antiretroviral regimen
DRUG: efavirenz containing antiretroviral regimen
DRUG: efavirenz containing antiretroviral regimen

Sponsor

Bristol-Myers Squibb